Effective patient engagement is crucial for the success of clinical trials, as it ensures active participation, improves recruitment rates, and enhances overall trial outcomes. In this section, we will discuss some possible strategies you can implement to enhance patient engagement and recruitment.
Enhancing disease understanding
Empowering rare disease patients begins with education of the disease from the moment of diagnosis. You can leverage the expertise of patient advocacy groups to build educational resources and support your research efforts. Ensuring that patients stay informed about new innovations, such as biomarker partnerships and patient-mediated data, allows for tailored and personalized care. Sharing accurate information through trusted sources, like physicians, will improve patient knowledge and acceptance of treatments.
Additionally, clear and frequent communication with patients, addressing their questions and explaining the risks and benefits, fosters an environment of trust. These strategies work together to empower patients, ensuring they are well- informed and engaged in their rare disease journey.
Raising awareness of studies
Raising awareness about clinical studies is crucial for advancing medical research and improving patient outcomes. To achieve this, you can consider the following recommendations:
Existing registries
Existing registries serve as valuable resources for connecting patients with relevant clinical studies. By leveraging these registries, researchers can reach out to potential participants who have already expressed interest in contributing to medical research. It’s important to note, however, that not all diseases will have an existing registry.
Awareness campaigns
Patient advocacy group (PAG) awareness campaigns play a vital role in disseminating information about clinical trials. Collaborating with PAGs allows for targeted and impactful outreach to patient communities, raising awareness and fostering a sense of urgency regarding the need for participation in clinical studies. Consideration should be given to funding screening programs through PAGs (e.g., newborn screening supported by NORD). This enables the identification of potential candidates for clinical trials, streamlining the recruitment process and ensuring a more efficient enrollment of eligible participants.
Another strategy would be to utilize sibling/family programs. These provide an opportunity to engage not only the affected individuals, but also their caregivers. They offer support, education, and a sense of community, while also raising awareness about ongoing clinical studies and the importance of participation.
Healthcare Provider presentations
Presentations by healthcare providers (HCPs) at conferences can be another way to effectively raise awareness among their peers and colleagues. Sharing knowledge about ongoing clinical studies, their objectives, and potential benefits encourages HCPs to refer eligible patients and collaborate with researchers.
Clinical Trial Educator deployment
Deploying Clinical Trial Educators (CTEs) can alleviate the burden on clinical trial sites while actively engaging patients. CTEs serve as dedicated resources, providing education, addressing queries, and guiding patients through the study enrollment process.
Launch platform
Creating a platform for launch throughout the interventional program ensures continuous awareness and engagement among patients, HCPs, and other stakeholders. Regular updates, educational materials, and interactive resources keep the community informed and foster a sense of involvement in the clinical study.
Identifying the right patients
Finding the right patients for a rare disease clinical study requires a comprehensive and patient-centric approach. See the figure below for key strategies to consider.
.png)
Representative Population
New requirements from the FDA (DEPICT Act) will necessitate changes in the way that industry approaches product development and study execution. [1] The concept of a representative population is a key focus, especially in rare disease, where diagnosed populations do not account for the underserved populations, owing to the diagnosis/genetic testing challenges. Clinical studies with representative populations help improve the strength and generatability of the studies’ results. The health differences that underserved populations experience are not mutually exclusive and can overlap, where one patient can be marginalized by more than one of these dimensions. A representative population encompasses health disparities, including not only race and ethnicity, but also sex, age, socioeconomic status, sexual orientation, and disability. These overlapping identities can compound to create unique experiences and highlight health disparities among certain populations. By understanding and addressing these intersectional challenges, you can foster a more comprehensive approach to clinical trial recruitment, engagement, and participation. Through targeted strategies, you can be intentional about this from the beginning of your trial lifecycle.
We have provided you with a sample checklist for operationalizing a representative population below.
Study Design – ensure that your representative population goals are established upfront and validated by real-world data
Site Selection – consider site staffing augmentation by need, including cultural research specialists
Site Activation
Recruitment Planning
Patient Recruitment
Community Engagement – Site-led activities
Community Engagement – Centralized activities
Enrollment
Engagement and Compliance
Refer and recruit
Streamlining the recruitment process is essential for identifying potential participants efficiently. Establishing physical referral hubs can facilitate seamless patient enrollment. Providing comprehensive recruitment support to patients, caregivers and healthcare providers can increase trial awareness and interest. Collaborating with specialists enables the understanding of current genetic testing protocols in both community and specialist practices.
Evaluating referral pathways helps identify suitable opportunities for introducing genetic testing and trial participation. It’s important to enhance patient convenience through easily accessible forms, information, audio-visual tools, and electronic consent processes.
Continue engaging with clinical trial participants beyond enrollment
Sustaining patient engagement beyond enrollment is crucial for successful clinical trial completion. Implementing a patient portal facilitates ongoing communication, updates, and access to trial-related information. Collaborating with external organizations and patient communities is another way to enhance engagement efforts and expand trial awareness.